Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Re (RMAX) EBIT (2016 - 2025)

Re (RMAX) has disclosed EBIT for 14 consecutive years, with $9.3 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIT rose 118.17% to $9.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.0 million, a 17.08% increase, with the full-year FY2025 number at $47.0 million, up 17.08% from a year prior.
  • EBIT was $9.3 million for Q4 2025 at Re, down from $18.3 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $18.3 million in Q3 2025 to a low of -$37.6 million in Q3 2021.
  • A 5-year average of $5.2 million and a median of $8.0 million in 2022 define the central range for EBIT.
  • Peak YoY movement for EBIT: crashed 501.11% in 2023, then soared 172.44% in 2024.
  • Re's EBIT stood at $10.4 million in 2021, then fell by 18.88% to $8.5 million in 2022, then crashed by 214.58% to -$9.7 million in 2023, then surged by 144.03% to $4.3 million in 2024, then surged by 118.17% to $9.3 million in 2025.
  • Per Business Quant, the three most recent readings for RMAX's EBIT are $9.3 million (Q4 2025), $18.3 million (Q3 2025), and $14.0 million (Q2 2025).